Synthesis of 2-[4,5-dimethyl-1-(phenylamino)-1H-imidazol-2-ylthio]-N-(thiazole-2-yl)acetamide derivatives and their anticancer activities
| dc.contributor.author | Duran, Murat | |
| dc.contributor.author | Demirayak, Şeref | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T20:01:45Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T20:01:45Z | |
| dc.date.issued | 2013 | |
| dc.department | İstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Ana Bilim Dalı | |
| dc.description | WOS: 000322181300007 | |
| dc.description.abstract | In this work, 2-(4,5-dimethyl-1-(phenylamino)-1H-imidazol-2-ylthio)-N-(thiazol-2-yl) acetamide derivatives were synthesized by reacting 4,5-dimethyl-1-(phenylamino)-1H-imidazole-2(3H)-thione derivatives with some 2-chloro-N-(thiazol-2-yl)acetamide compounds. The structure of synthesized compounds was confirmed by IR, H-1 NMR, and mass spectra. Anticancer activities of the compounds selected by the National Cancer Institute were investigated by testing against a panel of 60 different human tumor cell lines derived from nine neoplastic cancer types. Compounds 7, 13, and 23 exhibited reasonable anticancer activity against the screened cancer types with relatively low GI(50) values. The compounds showed high activity against melanoma-type cell lines. | |
| dc.description.sponsorship | Eskisehir Osmangazi University | en_US |
| dc.description.sponsorship | The authors would like to thank Eskisehir Osmangazi University for support and the National Cancer Institute (NCI), Bethesda, MD, USA, for in vitro screening of the compounds in human cancer cell lines. | en_US |
| dc.identifier.citation | Duran, M. ve Demirayak, Ş. (2013). Synthesis of 2-[4,5-dimethyl-1-(phenylamino)-1H-imidazol-2-ylthio]-N-(thiazole-2-yl)acetamide derivatives and their anticancer activities. Medıcınal Chemistry Research, 22(9), 4110-4124. https://dx.doi.org/10.1007/s00044-012-0411-5 | |
| dc.identifier.doi | 10.1007/s00044-012-0411-5 | |
| dc.identifier.endpage | 4124 | |
| dc.identifier.issn | 1054-2523 | |
| dc.identifier.issue | 9 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 4110 | |
| dc.identifier.uri | https://dx.doi.org/10.1007/s00044-012-0411-5 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/3428 | |
| dc.identifier.volume | 22 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Springer Birkhauser | |
| dc.relation.ispartof | Medıcınal Chemistry Research | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Imidazole | |
| dc.subject | Thiazole | |
| dc.subject | Anticancer | |
| dc.subject | Melanoma | |
| dc.subject | Acetamide | |
| dc.title | Synthesis of 2-[4,5-dimethyl-1-(phenylamino)-1H-imidazol-2-ylthio]-N-(thiazole-2-yl)acetamide derivatives and their anticancer activities | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Demirayak-Seref 2013.pdf
- Boyut:
- 344.27 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text











